SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arrowhead Resarch
ARWR 42.39+0.2%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Paul Lee2/29/2012 7:54:38 AM
   of 172
 


ArrowHead Research issued patent covering siRNA Inhibitors of HIF-2a






Arrowhead Research announced that the United States Patent and Trademark Office has issued U.S. Patent titled “Compositions and use of EPAS1 inhibitors.” Included in the patent are claims directed to siRNA sequences targeting the hypoxia-inducible factor 2 alpha gene (HIF-2a) or endothelial PAS domain protein 1, chemical modifications which enhance stability and/or biological activity, compositions, methods, and uses.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News